Clinical Trial Update: First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

View source ↗

Summary

A clinical trial evaluating first-line and neoadjuvant immunotherapy for gastric cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Advanced Gastric Cancer, Locally Advanced Gastric Carcinoma | Status: RECRUITING